← Leaderboards
Andrew Hix Bruening-Wright
Chantest, Inc.
$741,429
Attributed
$1,333,583
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $631.9K · FY2010–13$1M$750K$500K$250K$0
'10
'11
'12
'13
Funding mix
By agency
NIH$1,333,583 · 2
By mechanism
R44$1,184,308 · 1
R43$149,275 · 1
Top collaborators
- Arthur M Brown2 shared
Others in their field
Top investigators on “Predictive Value”
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$95,176,138
- Norman Wolmark · Nsabp Foundation, Inc.$56,895,191
- Peter B. Gilbert · Fred Hutchinson Cancer Center$55,156,953
- Holly Janes · Fred Hutchinson Cancer Center$53,485,407
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- Robert J. Ursano · Henry M. Jackson Fdn For The Adv Mil/Med$42,497,358
Research focus
Predictive ValueStem Cell PopulationIon ChannelPre-ClinicalSafety TestingScreening ProcedureEventHeart CellMuscle CellsPharmacologyResponseSafetyBaseCellsAction PotentialsDrug DevelopmentClinical TrialsCardiacCardiac MyocytesMarketingPharmacologic SubstanceCostPublic Health Medicine (Field)Stem Cells
Grant awards (3)
Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car$552,449
R44 · FY2013 · HL · contact PI
Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car$631,859
R44 · FY2012 · HL · contact PI
Optimizing the Action Potential of Stem Cell-derived Human Cardiomyocytes for Car$149,275
R43 · FY2010 · HL · contact PI